William Shell, CEO & Chief Scientific Officer, 10% Owner at Targeted Medical Pharma, Inc. (TRGM), sold 150,000 shares at $0.60 ($90K) on 2014-04-10, disclosed to the SEC on 2014-04-10.
Open-market sale of $90k TRGM by CEO & Chief Scientific Officer, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TRGM | SELL | 2013-09-20 | $2K | — | Filing → |
| PrivateTargeted Medical Pharma, Inc. | BUY | 2013-07-23 | $269K | — | Filing → |